{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:44:43Z","timestamp":1790372683292,"version":"4.1.0"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019345","name":"King Salman Center for Disability Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Individuals with Down syndrome exhibit various changes in the human body systems, including alterations in the ocular, neurological, and dermatological systems. Especially, preclinical and clinical studies have determined Down syndrome patients to possess reduced intellectual and cognition abilities, which neurobehavioral effects are associated with altered molecular markers in the brain. For instance, neuroinflammation and increased brain oxidative stress are reported in animals models of Down syndrome, and the reversal of those markers lead to positive effects. Dopaminergic and serotonergic neurons are altered in individuals with Down syndrome, with dopamine and serotonin secretion reduced and their transporters upregulated. Hence, blocking reuptake of dopamine and serotonin might improve Down syndrome behavioral impairments. Norepinephrine loss was observed in a mouse model of Down syndrome, and treatment with a \u03b22 adrenergic receptor agonist improved behavioral symptoms. Moreover, targeting certain glutamatergic receptors, particularly in the hippocampus, might correct the glutamatergic dysfunction and altered behaviors. Inverse agonists or antagonists of GABAergic receptors suppress GABA\u2019s inhibitory role, an effect associated with improved cognition behaviors in models of Down syndrome. Reports also suggest partial involvement of the histaminergic system in the impairment of memory function observed in Down syndrome. Finally, cholinergic system alteration has been reported, but the therapeutic role of its modulation needs further investigation. This review collects and reports multi-Omics Studies on Down syndrome, the crucial roles of inflammation, oxidative stress independently as well as role of oxidative stress in pregnancies with Down Syndrome and biomarkers of maternal diagnosis of Down syndrome. This review further explained the role of neurotransmitter pathways in Down syndrome pathogenesis, prognosis and therapeutic intervention for Down syndrome and future directions for interventions.<\/jats:p>","DOI":"10.3389\/fphar.2025.1592277","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:30:29Z","timestamp":1745818229000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Current insights and prospects for the pathogenesis and treatment of clinical manifestations associated with Down syndrome through neurotransmitter, inflammatory, and oxidative stress pathways"],"prefix":"10.3389","volume":"16","author":[{"given":"Fawaz","family":"Alasmari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sary","family":"Alsanea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa M.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Al-Qerem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12098-013-1249-7","article-title":"Diagnosis and management of Down syndrome","volume":"81","author":"Agarwal Gupta","year":"2014","journal-title":"Indian J. Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0150137","DOI":"10.1371\/journal.pone.0150137","article-title":"Up regulation of cystathione \u03b3 lyase and hydrogen sulphide in the myocardium inhibits the progression of isoproterenol\u2013caffeine induced left ventricular hypertrophy in Wistar kyoto rats","volume":"11","author":"Ahmad","year":"2016","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrg1448","article-title":"Chromosome 21 and down syndrome: from genomics to pathophysiology","volume":"5","author":"Antonarakis","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0887-8994(96)00167-1","article-title":"Excessive glutamate receptor 1 immunoreactivity in adult Down syndrome brains","volume":"15","author":"Arai","year":"1996","journal-title":"Pediatr. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1399-0004.1976.tb00041.x","article-title":"Alpha-1-antitrypsin (Pi) types in Down\u2019s syndrome","volume":"10","author":"Arnaud","year":"1976","journal-title":"Clin. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12929-015-0138-y","article-title":"Down syndrome: an insight of the disease","volume":"22","author":"Asim","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5152\/jtgga.2012.43","article-title":"Medicine in stamps: history of Down syndrome through philately","volume":"13","author":"Ataman","year":"2012","journal-title":"J. Turkish Ger. Gynecol. Assoc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2174\/1386207322666191008214919","article-title":"Role of ischemia modified albumin serum levels as an oxidative stress marker in children with diabetic ketoacidosis","volume":"22","author":"Ayar","year":"2019","journal-title":"Comb. Chem. and High Throughput Screen."},{"key":"B10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.freeradbiomed.2016.10.508","article-title":"HNE-modified proteins in Down syndrome: involvement in development of Alzheimer disease neuropathology","volume":"111","author":"Barone","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.irrdd.2022.09.004","article-title":"Neurological and neurodevelopmental manifestations in children and adolescents with Down syndrome","volume":"63","author":"Baumer","year":"2022","journal-title":"Int. Rev. Res. Dev. Disabil."},{"key":"B12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0006-2944(74)90056-8","article-title":"A comparison of the serotonin and ATP content in platelets from subjects with Down\u2019s syndrome","volume":"9","author":"Bayer","year":"1974","journal-title":"Biochem. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2013.11.010","article-title":"Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome","volume":"63","author":"Begenisic","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0304-3940(03)00260-x","article-title":"Altered glutamate uptake in peripheral tissues from Down syndrome patients","volume":"343","author":"Begni","year":"2003","journal-title":"Neurosci. Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000236899","article-title":"A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells","volume":"31","author":"Bhattacharyya","year":"2009","journal-title":"Dev. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1177\/0269881111405366","article-title":"Specific targeting of the GABA-A receptor \u03b15 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice","volume":"25","author":"Braudeau","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"105316","DOI":"10.1016\/j.parkreldis.2023.105316","article-title":"Classification and staging of Parkinson\u2019s disease using video-based eye tracking","volume":"110","author":"Brien","year":"2023","journal-title":"Park. and Relat. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/jcm10112382","article-title":"Prenatal screening of trisomy 21: could oxidative stress markers play a role?","volume":"10","author":"Buczy\u0144ska","year":"2021","journal-title":"J. Clin. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/378776a0","article-title":"Apoptosis and increased generation of reactive oxygen species in Down\u2019s syndrome neurons in vitro","volume":"378","author":"Busciglio","year":"1995","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuropharm.2019.05.016","article-title":"Atomoxetine improves memory and other components of executive function in young-adult rats and aged rhesus monkeys","volume":"155","author":"Callahan","year":"2019","journal-title":"Neuropharmacology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/0971-5916.164218","article-title":"Oxidative stress, thyroid dysfunction and Down syndrome","volume":"142","author":"Campos","year":"2015","journal-title":"Indian J. Med. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43161-025-00280-4","article-title":"Effects of dual task on functional mobility in individuals with Down syndrome: a case\u2013control study","volume":"30","author":"Carvalho","year":"2025","journal-title":"Bull. Fac. Phys. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-14-400","article-title":"Follow-up in healthy schoolchildren and in adolescents with Down syndrome: psycho-environmental and genetic determinants of physical activity and its impact on fitness, cardiovascular diseases, inflammatory biomarkers and mental health; the UP&DOWN study","volume":"14","author":"Castro-Pi\u00f1ero","year":"2014","journal-title":"BMC Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nlm.2007.05.007","article-title":"Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome","volume":"89","author":"Chang","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF02913070","article-title":"Ischemia modified albumin: a novel marker for acute coronary syndrome","volume":"21","author":"Chawla","year":"2006","journal-title":"Indian J. Clin. Biochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/s24051572","article-title":"Machine learning and digital biomarkers can detect early stages of neurodegenerative diseases","volume":"24","author":"Chudzik","year":"2024","journal-title":"Sensors"},{"key":"B28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.expneurol.2006.02.005","article-title":"Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome","volume":"200","author":"Clark","year":"2006","journal-title":"Exp. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/bph.12169","article-title":"Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down\u2019s syndrome","volume":"169","author":"Colas","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41413-021-00137-1","article-title":"Sympathetic activity in breast cancer and metastasis: partners in crime","volume":"9","author":"Concei\u00e7\u00e3o","year":"2021","journal-title":"Bone Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fncel.2017.00054","article-title":"The GABAergic hypothesis for cognitive disabilities in down syndrome","volume":"11","author":"Contestabile","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"383170","DOI":"10.1155\/2012\/383170","article-title":"Oxidative stress and mitochondrial dysfunction in Down\u2019s syndrome: relevance to aging and dementia","volume":"2012","author":"Coskun","year":"2012","journal-title":"Curr. Gerontology Geriatrics Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/sj.npp.1301535","article-title":"Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test","volume":"33","author":"Costa","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/18715273113126660183","article-title":"The glutamatergic hypothesis for Down syndrome: the potential use of N-methyl-D-aspartate receptor antagonists to enhance cognition and decelerate neurodegeneration","volume":"13","author":"Cs Costa","year":"2014","journal-title":"CNS and Neurological Disorders-Drug Targets (Formerly Curr. Drug Targets-CNS and Neurological Disord.)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biopsych.2013.05.024","article-title":"Formoterol, a long-acting \u03b22 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome","volume":"75","author":"Dang","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pnpbp.2014.05.004","article-title":"Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome","volume":"54","author":"Das","year":"2014","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s11064-007-9581-9","article-title":"Lack of association between Down syndrome and polymorphisms in dopamine receptor D4 and serotonin transporter genes","volume":"33","author":"Das Bhowmik","year":"2008","journal-title":"Neurochem. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1177\/1535370215593826","article-title":"Galectin-3 in autoimmunity and autoimmune diseases","volume":"240","author":"De Oliveira","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e078897","DOI":"10.1002\/alz.078897","article-title":"Amyloid deposition and neuroinflammation in middle-aged to older individuals with Down syndrome: a PET evaluation","volume":"19","author":"De Oliveira","year":"2023","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pnpbp.2014.05.011","article-title":"Targeting the \u03b17 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down\u2019s syndrome","volume":"54","author":"Deutsch","year":"2014","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bcp.2015.06.005","article-title":"The \u03b17 nicotinic acetylcholine receptor: a mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome","volume":"97","author":"Deutsch","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1089\/ars.2016.6759","article-title":"The triangle of death in Alzheimer\u2019s disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein homeostasis revealed by redox proteomics","volume":"26","author":"Di Domenico","year":"2017","journal-title":"Antioxidants and Redox Signal."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3233\/JAD-141254","article-title":"Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1\/BVR-a system: insights for transition to Alzheimer\u2019s disease","volume":"44","author":"Di Domenico","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2017.08.009","article-title":"mTOR in Down syndrome: role in A\u00df and tau neuropathology and transition to Alzheimer disease-like dementia","volume":"114","author":"Di Domenico","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fnins.2020.00670","article-title":"Down syndrome is a metabolic disease: altered insulin signaling mediates peripheral and brain dysfunctions","volume":"14","author":"Dierssen","year":"2020","journal-title":"Front. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0006-8993(96)01173-0","article-title":"Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome","volume":"749","author":"Dierssen","year":"1997","journal-title":"Brain Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3109\/14767058.2012.697943","article-title":"Ischemia-modified albumin (IMA): could it be useful to predict perinatal asphyxia?","volume":"25","author":"Dursun","year":"2012","journal-title":"J. Maternal-Fetal and Neonatal Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1192\/bjp.2017.21","article-title":"Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study","volume":"212","author":"Eady","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12013-024-01248-2","article-title":"Oxidative stress, endoplasmic reticulum stress and apoptosis in the pathology of Alzheimer\u2019s disease","volume":"82","author":"Ekundayo","year":"2024","journal-title":"Cell Biochem. Biophysics"},{"key":"B50","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-6262-0_17","volume-title":"Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer\u2019s disease","author":"Engidawork","year":"2001"},{"key":"B51","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nn1860","article-title":"Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome","volume":"10","author":"Fernandez","year":"2007","journal-title":"Nat. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1093\/brain\/awaa326","article-title":"Evolution of neuroinflammation across the lifespan of individuals with Down syndrome","volume":"143","author":"Flores-Aguilar","year":"2020","journal-title":"Brain"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1523\/JNEUROSCI.2658-14.2015","article-title":"Designer receptors enhance memory in a mouse model of Down syndrome","volume":"35","author":"Fortress","year":"2015","journal-title":"J. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2017.09.021","article-title":"Increased levels of inflammatory plasma markers and obesity risk in a mouse model of Down syndrome","volume":"114","author":"Fructuoso","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B55","first-page":"1607","article-title":"Oxidative stress and hematologic and biochemical parameters in individuals with Down syndrome","author":"Garcez","year":"2005"},{"key":"B56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tips.2009.10.010","article-title":"Molecular basis of pharmacotherapies for cognition in Down syndrome","volume":"31","author":"Gardiner","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.lfs.2013.08.017","article-title":"Systemic oxidative stress in children and teenagers with Down syndrome","volume":"93","author":"Garlet","year":"2013","journal-title":"Life Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2788.1990.tb01529.x","article-title":"Dietary increase in serotonin reduces self-injurious behaviour in a Down\u2019s syndrome adult","volume":"34","author":"Gedye","year":"1990","journal-title":"J. Intellect. Disabil. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/089198879701000302","article-title":"Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs","volume":"10","author":"Geldmacher","year":"1997","journal-title":"J. Geriatric Psychiatry Neurology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e25002","DOI":"10.1002\/jcla.25002","article-title":"Periodontal disease in down syndrome: predisposing factors and potential non-surgical therapeutic approaches","volume":"38","author":"Ghaffarpour","year":"2024","journal-title":"J. Clin. Laboratory Analysis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s11689-022-09418-0","article-title":"A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-\u03b15 NAM (basmisanil) on intellectual disability associated with Down syndrome","volume":"14","author":"Goeldner","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fnmol.2018.00226","article-title":"Phosphoproteomic alterations of ionotropic glutamate receptors in the hippocampus of the Ts65Dn mouse model of Down syndrome","volume":"11","author":"G\u00f3mez De Salazar","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0304-3940(00)01624-4","article-title":"Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome","volume":"296","author":"Gulesserian","year":"2000","journal-title":"Neurosci. Lett."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.3390\/diagnostics12122975","article-title":"A review of the recent advances in Alzheimer\u2019s disease research and the utilization of network biology approaches for prioritizing diagnostics and therapeutics","volume":"12","author":"Hajjo","year":"2022","journal-title":"Diagnostics"},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780198717478.001.0001","volume-title":"Free radicals in biology and medicine","author":"Halliwell","year":"2015"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/glia.23779","article-title":"RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome","volume":"68","author":"Hamlett","year":"2020","journal-title":"Glia"},{"key":"B67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.freeradbiomed.2017.08.028","article-title":"Exosomal biomarkers in Down syndrome and Alzheimer\u2019s disease","volume":"114","author":"Hamlett","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","article-title":"Down syndrome and Alzheimer\u2019s disease: common pathways, common goals","volume":"11","author":"Hartley","year":"2015","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"7432797","DOI":"10.1155\/2016\/7432797","article-title":"Oxidative stress and inflammation: what polyphenols can do for us?","volume":"2016","author":"Hussain","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2014.09.039","article-title":"Comparative proteomic profiling reveals aberrant cell proliferation in the brain of embryonic Ts1Cje, a mouse model of Down syndrome","volume":"281","author":"Ishihara","year":"2014","journal-title":"Neuroscience"},{"key":"B71","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.dscb.2023.100114","article-title":"The role of Memantine in slowing cognitive decline in patients with Down syndrome\u2013A systematic review and meta analysis","volume":"13","author":"Islam","year":"2024","journal-title":"Brain Disord."},{"key":"B72","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2174\/1567205011666140812115423","article-title":"Metabotropic glutamate receptor 5 in Down\u2019s syndrome hippocampus during development: increased expression in astrocytes","volume":"11","author":"Iyer","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in Down syndrome: molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1021\/acs.jmedchem.8b00185","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors as potential therapeutics","volume":"61","author":"Jarhad","year":"2018","journal-title":"J. Med. Chem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1352\/0895-8017(2003)108<367:EODOCF>2.0.CO;2","article-title":"Effects of donepezil on cognitive functioning in Down syndrome","volume":"108","author":"Johnson","year":"2003","journal-title":"Am. J. Ment. Retard."},{"key":"B76","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1523\/JNEUROSCI.5338-13.2014","article-title":"Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down\u2019s syndrome","volume":"34","author":"Kaur","year":"2014","journal-title":"J. Neurosci."},{"key":"B77","first-page":"125","article-title":"Down syndrome: current status, challenges and future perspectives","volume":"5","author":"Kazemi","year":"2016","journal-title":"Int. J. Mol. Cell. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0304-3940(01)01545-2","article-title":"Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer\u2019s disease","volume":"300","author":"Kim","year":"2001","journal-title":"Neurosci. Lett."},{"key":"B79","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0304-3940(02)00051-4","article-title":"Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick\u2019s disease","volume":"321","author":"Kim","year":"2002","journal-title":"Neurosci. Lett."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/j.1471-4159.1989.tb01864.x","article-title":"Down\u2019s syndrome individuals begin life with normal levels of brain cholinergic markers","volume":"52","author":"Kish","year":"1989","journal-title":"J. Neurochem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1002\/ajmg.a.33730","article-title":"Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10\u201317","volume":"152","author":"Kishnani","year":"2010","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B82","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1523\/JNEUROSCI.1766-04.2004","article-title":"Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome","volume":"24","author":"Kleschevnikov","year":"2004","journal-title":"J. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"11848","DOI":"10.1523\/JNEUROSCI.2985-10.2010","article-title":"Norepinephrine promotes microglia to uptake and degrade amyloid \u03b2 peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme","volume":"30","author":"Kong","year":"2010","journal-title":"J. Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","article-title":"PPARgamma agonists as therapeutics for the treatment of Alzheimer\u2019s disease","volume":"5","author":"Landreth","year":"2008","journal-title":"Neurotherapeutics"},{"key":"B85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/13872877241283675","article-title":"Extra virgin olive oil beneficial effects on memory, synaptic function, and neuroinflammation in a mouse model of Down syndrome","volume":"102","author":"Li","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"114062","DOI":"10.1016\/j.ejmech.2021.114062","article-title":"DYRK1A inhibitors for disease therapy: current status and perspectives","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bbr.2010.03.036","article-title":"Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome","volume":"221","author":"Lockrow","year":"","journal-title":"Behav. Brain Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/JAD-2010-101218","article-title":"A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model","volume":"23","author":"Lockrow","year":"","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.12659\/MSM.893377","article-title":"Delays in motor development in children with Down syndrome","volume":"21","author":"Malak","year":"2015","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","article-title":"Autoimmunity in Down\u2019s syndrome via cytokines, CD4 T cells and CD11c+ B cells","volume":"615","author":"Malle","year":"2023","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/jnnp.50.3.341","article-title":"Dopaminergic neurotransmitter systems in Alzheimer\u2019s disease and in Down\u2019s syndrome at middle age","volume":"50","author":"Mann","year":"1987","journal-title":"J. Neurology, Neurosurg. and Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1080\/10715762.2016.1253833","article-title":"Increased non-protein bound iron in Down syndrome: contribution to lipid peroxidation and cognitive decline","volume":"50","author":"Manna","year":"2016","journal-title":"Free Radic. Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41586-024-07946-4","article-title":"Single-cell multi-omics map of human fetal blood in Down syndrome","volume":"634","author":"Marderstein","year":"2024","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1056\/NEJM197410312911807","article-title":"Decreased ATPase and increased sodium content of platelets in Down\u2019s syndrome: relation to decreased serotonin content","volume":"291","author":"Mccoy","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00429-017-1563-3","article-title":"GABA A receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome","volume":"223","author":"Milenkovic","year":"2018","journal-title":"Brain Struct. Funct."},{"key":"B96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-443-23826-0.00001-5","article-title":"Advances in CRISPER\/Cas system and genome editing technologies for the treatment of neurodegenerative diseases","volume-title":"Genome editing for neurodegenerative diseases","author":"Mishra","year":"2025"},{"key":"B97","doi-asserted-by":"publisher","first-page":"535","DOI":"10.33549\/physiolres.932722","article-title":"Oxidative stress and Down syndrome. Do antioxidants play a role in therapy?","volume":"63","author":"Muchov\u00e1","year":"2014","journal-title":"Physiological Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1391564","DOI":"10.3389\/fnmol.2024.1391564","article-title":"Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions","volume":"17","author":"Murphy","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/jnen\/59.11.1011","article-title":"Neuronal oxidative stress precedes amyloid-\u03b2 deposition in Down syndrome","volume":"59","author":"Nunomura","year":"2000","journal-title":"J. Neuropathology and Exp. Neurology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s004010050985","article-title":"The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down\u2019s syndrome brains","volume":"97","author":"Oka","year":"1999","journal-title":"Acta Neuropathol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10522-006-9002-5","article-title":"Multiple evidence for an early age pro-oxidant state in Down Syndrome patients","volume":"7","author":"Pallard\u00f3","year":"2006","journal-title":"Biogerontology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1080\/14656566.2018.1529167","article-title":"Pharmacotherapy of Down syndrome","volume":"19","author":"Palumbo","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"B103","doi-asserted-by":"publisher","first-page":"724904","DOI":"10.1155\/2012\/724904","article-title":"Oxidative stress and Down syndrome: a route toward Alzheimer-like dementia","volume":"2012","author":"Perluigi","year":"2012","journal-title":"Curr. Gerontology Geriatrics Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/prca.201000121","article-title":"Oxidative stress occurs early in Down syndrome pregnancy: a redox proteomics analysis of amniotic fluid","volume":"5","author":"Perluigi","year":"2011","journal-title":"Proteomics\u2013Clinical Appl."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.bbadis.2014.04.007","article-title":"Neuropathological role of PI3K\/Akt\/mTOR axis in Down syndrome brain","volume":"1842","author":"Perluigi","year":"2014","journal-title":"Biochimica Biophysica Acta (BBA)-Molecular Basis Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clinbiochem.2006.10.019","article-title":"Early oxidative stress in amniotic fluid of pregnancies with Down syndrome","volume":"40","author":"Perrone","year":"2007","journal-title":"Clin. Biochem."},{"key":"B107","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12883-018-1140-2","article-title":"Altered development of dopaminergic neurons differentiated from stem cells from human exfoliated deciduous teeth of a patient with Down syndrome","volume":"18","author":"Pham","year":"2018","journal-title":"BMC Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainres.2017.09.035","article-title":"Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer\u2019s disease","volume":"1702","author":"Ponnusamy","year":"2019","journal-title":"Brain Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00383-024-05792-z","article-title":"A multi-center cross-sectional comparison of parent-reported quality of life and bowel function between anorectal malformation and Hirschsprung\u2019s disease patients with versus those without Down syndrome","volume":"40","author":"Rajasegaran","year":"2024","journal-title":"Pediatr. Surg. Int."},{"key":"B110","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in Down syndrome","volume":"164","author":"Ram","year":"2011","journal-title":"Clin. and Exp. Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.nrleng.2021.10.010","article-title":"Relationship between inflammation and oxidative stress and its effect on multiple sclerosis","volume":"39","author":"Ramos-Gonz\u00e1lez","year":"2021","journal-title":"Neurolog\u00eda"},{"key":"B112","volume-title":"Multi-omics approach in Down syndrome resolves new regulators in two regions of the human brain","author":"Rastogi","year":"2021"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/j.1582-4934.2008.00478.x","article-title":"Proteomic identification of nitrated brain proteins in early Alzheimer\u2019s disease inferior parietal lobule","volume":"13","author":"Reed","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cca.2014.03.002","article-title":"Alterations of ectonucleotidases and acetylcholinesterase activities in lymphocytes of Down syndrome subjects: relation with inflammatory parameters","volume":"433","author":"Rodrigues","year":"2014","journal-title":"Clin. Chim. acta"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e210179","DOI":"10.1212\/wnl.0000000000210179","article-title":"Posterior cortical atrophy due to Alzheimer disease in a person with down syndrome: a case report","volume":"104","author":"Rodr\u00edguez-Baz","year":"2025","journal-title":"Neurology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.82446","article-title":"Temporal and spatial differential expression of glutamate receptor genes in the brain of down syndrome","author":"Rodr\u00edguez Ortiz","year":"2019","journal-title":"Gene Regul."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down\u2019s syndrome","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"B118","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neulet.2007.12.039","article-title":"Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome","volume":"433","author":"Rueda","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B120","doi-asserted-by":"publisher","first-page":"7ra17","DOI":"10.1126\/scitranslmed.3000258","article-title":"Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome","volume":"1","author":"Salehi","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0304-3940(97)13379-1","article-title":"Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease","volume":"222","author":"Schneider","year":"1997","journal-title":"Neurosci. Lett."},{"key":"B122","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1101\/lm.024182.111","article-title":"Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine","volume":"18","author":"Scott-Mckean","year":"2011","journal-title":"Learn. and Mem."},{"key":"B123","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-6380-1_14","volume-title":"Serotonin (5-HT) in brains of adult patients with Down syndrome","author":"Seidl","year":"1999"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2017.03.009","article-title":"Ts1Cje Down syndrome model mice exhibit environmental stimuli-triggered locomotor hyperactivity and sociability concurrent with increased flux through central dopamine and serotonin metabolism","volume":"293","author":"Shimohata","year":"2017","journal-title":"Exp. Neurol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0753-3322(94)90140-6","article-title":"Mapping of the Down syndrome phenotype on chromosome 21 at the molecular level","volume":"48","author":"Sinet","year":"1994","journal-title":"Biomed. and Pharmacother."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/ajmg.a.33082","article-title":"Prenatal diagnosis of Down syndrome: how best to deliver the news","volume":"149","author":"Skotko","year":"2009","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B127","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fnbeh.2015.00265","article-title":"Timing of therapies for Down syndrome: the sooner, the better","volume":"9","author":"Stagni","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/1567205012666150921100311","article-title":"Maternal choline supplementation: a potential prenatal treatment for Down syndrome and Alzheimer\u2019s disease","volume":"13","author":"Strupp","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pnpbp.2008.10.006","article-title":"Oxidative stress and cognitive ability in adults with Down syndrome","volume":"33","author":"Strydom","year":"2009","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B130","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1096\/fba.2021-00086","article-title":"Dopamine-related oxidative stress and mitochondrial dysfunction in dopaminergic neurons differentiated from deciduous teeth-derived stem cells of children with Down syndrome","volume":"4","author":"Sun","year":"2022","journal-title":"FASEB BioAdvances"},{"key":"B131","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.braindev.2015.06.006","article-title":"Effects of donepezil and serotonin reuptake inhibitor on acute regression during adolescence in Down syndrome","volume":"38","author":"Tamasaki","year":"2016","journal-title":"Brain Dev."},{"key":"B132","doi-asserted-by":"publisher","first-page":"6937154","DOI":"10.1155\/2020\/6937154","article-title":"Neuroinflammatory markers in the serum of prepubertal children with Down syndrome","volume":"2020","author":"Tarani","year":"2020","journal-title":"J. Immunol. Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/brainsci11091216","article-title":"Selective serotonin reuptake inhibitors for the treatment of depression in adults with Down syndrome: a preliminary retrospective chart review study","volume":"11","author":"Thom","year":"2021","journal-title":"Brain Sci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1171797","DOI":"10.3389\/fnins.2023.1171797","article-title":"Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome","volume":"17","author":"Thomazeau","year":"2023","journal-title":"Front. Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1300\/J229v08n03_05","article-title":"\u201cDown will come baby\u201d: prenatal stress, primitive defenses and gestational dysregulation","volume":"8","author":"Thomson","year":"2007","journal-title":"J. Trauma and Dissociation"},{"key":"B136","doi-asserted-by":"publisher","first-page":"156910","DOI":"10.1016\/j.cyto.2025.156910","article-title":"Association between serum levels of inflammatory mediators and periodontitis severity in people with Down syndrome","volume":"189","author":"Veloso","year":"2025","journal-title":"Cytokine"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.104981","article-title":"Prenatal diagnosis: the main advances in the application of identification of biomarkers based on multi-omics","author":"Wang","year":"2022","journal-title":"IntechOpen"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e1465","DOI":"10.1542\/peds.2006-3448","article-title":"Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development","volume":"120","author":"Whittle","year":"2007","journal-title":"Pediatrics"},{"key":"B139","doi-asserted-by":"publisher","first-page":"170276","DOI":"10.1155\/2012\/170276","article-title":"Neuroinflammation in the aging down syndrome brain; lessons from Alzheimer\u2019 s disease","volume":"2012","author":"Wilcock","year":"2012","journal-title":"Curr. gerontology geriatrics Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1742-2094-10-84","article-title":"Down\u2019s syndrome, neuroinflammation, and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.neurobiolaging.2015.05.016","article-title":"Down syndrome individuals with Alzheimer\u2019s disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer\u2019s disease","volume":"36","author":"Wilcock","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/brain\/awy159","article-title":"Trisomy of human chromosome 21 enhances amyloid-\u03b2 deposition independently of an extra copy of APP","volume":"141","author":"Wiseman","year":"2018","journal-title":"Brain"},{"key":"B143","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1472-6823-12-22","article-title":"Leptin, insulin and thyroid hormones in a cohort of Egyptian obese Down syndrome children: a comparative study","volume":"12","author":"Yahia","year":"2012","journal-title":"BMC Endocr. Disord."},{"key":"B144","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s42003-025-07903-5","article-title":"Norepinephrine regulates epithelial-derived neurotrophins expression and sensory nerve regeneration through ADRB2 receptor","volume":"8","author":"Yuan","year":"2025","journal-title":"Commun. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1592277\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:30:32Z","timestamp":1745818232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1592277\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":144,"alternative-id":["10.3389\/fphar.2025.1592277"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1592277","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1592277"}}